New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
09:02 EDTMAPP, AGNAllergan, MAP announce FTC grants early termination of waiting period
Allergan (AGN) and MAP Pharmaceuticals (MAPP) announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, with respect to the tender offer for all of the outstanding shares of common stock of MAP by Groundhog Acquisition, a wholly-owned subsidiary of Allergan. As previously announced, on January 31, Purchaser initiated a tender offer to purchase all outstanding shares of common stock of MAP for $25.00 per share, net to the seller in cash, without interest and less any applicable withholding taxes. Completion of the tender offer remains subject to other customary conditions as set forth in the Offer to Purchase filed by Purchaser and Allergan with the U.S. SEC on January 31, including the tender of at least a majority of the outstanding shares of common stock of MAP on a fully diluted basis. The tender offer and withdrawal rights are scheduled to expire at 12:00 midnight, New York City time, on the night of February 28.
News For AGN;MAPP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 15, 2015
10:29 EDTAGNAmerican Urological Association to hold an annual meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use